Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study

[1] Abel JL(1914)Plasma removal with return of corpuscles (plasmaphaeresis) J Pharmacol Exp Ther 5 625-641

[2] Rowntree LG(1983)Intensive plasma exchange in small and critically ill pediatric patients: techniques and clinical outcome J Clin Apher 1 215-224

[3] Turner BB(1984)A comparison of centrifugal and membrane-based apheresis formats Int J Artif Organs 7 35-38

[4] Fosburg M(2014)Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients BMC Anesthesiol 14 24-58

[5] Dolan M(2015)Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation J Heart Lung Transplant 34 50-3815

[6] Propper R(2012)Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing Nephrol Dial Transplant 27 3807-73

[7] Wolfe L(2010) O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry Ther Apher Dial 14 52-981

[8] Kevy S(1990)Apheresis technologies and clinical applications: the 2007 International Apheresis Registry Kidney Int 38 976-249

[9] Gurland HJ(2010)Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients J Clin Apher 25 240-168

[10] Lysaght MJ(2011)Introduction and overview of therapeutic apheresis Crit Care 15 202-284

[1] Abel JL(1914)Plasma removal with return of corpuscles (plasmaphaeresis) J Pharmacol Exp Ther 5 625-641

[2] Rowntree LG(1983)Intensive plasma exchange in small and critically ill pediatric patients: techniques and clinical outcome J Clin Apher 1 215-224

[3] Turner BB(1984)A comparison of centrifugal and membrane-based apheresis formats Int J Artif Organs 7 35-38

[4] Fosburg M(2014)Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients BMC Anesthesiol 14 24-58

[5] Dolan M(2015)Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation J Heart Lung Transplant 34 50-3815

[6] Propper R(2012)Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing Nephrol Dial Transplant 27 3807-73

[7] Wolfe L(2010) O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry Ther Apher Dial 14 52-981

[8] Kevy S(1990)Apheresis technologies and clinical applications: the 2007 International Apheresis Registry Kidney Int 38 976-249

[9] Gurland HJ(2010)Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients J Clin Apher 25 240-168

[10] Lysaght MJ(2011)Introduction and overview of therapeutic apheresis Crit Care 15 202-284